Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GTI PROVIDES VECTORS FOR TRIAL

Dec. 16, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 16, 1991

CETUS, DU PONT SETTLE PCR DISPUTE

Dec. 16, 1991

CENTOCOR ORDERED TO PAY ROYALTIES

Dec. 13, 1991

FDA PANEL RECOMMENDS FACTOR VIII

Dec. 13, 1991

HEPARIN DERIVATIVE ENHANCES HEALING

Dec. 13, 1991

LIPOSOMAL AMBISOME CURES LIVER INFECTION

Dec. 13, 1991

LIGAND LICENSES ASSAY TO EVALUATE DRUGS

Dec. 13, 1991

RECOMMENDATION PUSHES CYTRX STOCK

Dec. 13, 1991

DECISION ON CIBA INJUNCTION MOVED UP

Dec. 13, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...